Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Insulin Aspart Injection（UBLIN®）
United Therapeutics Europe Ltd
Pharmacokinetics and Pharmacodynamics
1 trial -
Intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Intensive BP control
Chinese University of Hong Kong
Primary Hypertension
1 trial -
Intensive BP treatment group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Interleukin-2
The First People's Hospital of Lianyungang
Beta Thalassemia Major
1 trial -
Intestinal Microbiota Transplant (IMT) Capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Intra-arterial administration of neuroprotective agents
Hui-Sheng Chen
Ischemic Stroke
1 trial -
Intrathecal recombinant human alpha iduronidase
Ultragenyx UK Limited
Mucopolysaccharidosis I
1 trial -
Intrauterine lavage therapy
The First People's Hospital of Lianyungang
Intrauterine Adhesions
1 trial -
Intravenous Vitamin C
United Therapeutics Europe Ltd
Burns
1 trial -
Intravenous administration of ferric carboxymaltose
United Therapeutics Europe Ltd
Lung Hypoxia
1 trial -
Intravenous sedation
United Therapeutics Europe Ltd
Lower Back Pain
1 trial -
Intravenous thrombolysis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Intravenous tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Catheter Site Discomfort
1 trial -
Irinotecan Hydrochloride Liposome Injection；Carboplatin Injection；Serplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
Isosorbide Dinitrate 5 MG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Post-ERCP Acute Pancreatitis
1 trial -
Ivosidenib,Venetoclax,gilteritinib,Selinexor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial -
Jelly confectionary Snakes
United Therapeutics Europe Ltd
POSTOP NAUSEA VOMITING
1 trial -
Ketamine
The First People's Hospital of Lianyungang
Intensive Care Unit
1 trial -
Ketogenic Diet
United Therapeutics Europe Ltd
CNS Oxygen Toxicity, Ketogenic Diet
1 trial -
Ketogenic diet
United Therapeutics Europe Ltd
Heart Failure With Preserved Ejection Fraction
1 trial -
Ketogenic food products
United Therapeutics Europe Ltd
Oxygen Toxicity
2 trials -
Ketone ester
United Therapeutics Europe Ltd
Ketosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources